Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
Journal of Cell Science
|
June 1, 1994
Vimentin's tail interacts with actin-containing structures in vivo
R B Cary, M W Klymkowsky, R M Evans, et al.
The Journal of Biological Chemistry
|
November 15, 1986
Isolation and characterization of a collagen binding domain in human von Willebrand factor
F I Pareti, Y Fujimura, J A Dent, et al.
American Journal of Hematology
|
December 1, 1989
Type II H von Willebrand disease: new structural abnormality of plasma and platelet von Willebrand factor in a patient with prolonged bleeding time and borderline levels of ristocetin cofactor activity
A B Federici, P M Mannucci, R Lombardi, et al.
The Journal of Biological Chemistry
|
April 25, 2000
Modeling and functional analysis of the interaction between von Willebrand factor A1 domain and glycoprotein Ibalpha
S Vasudevan, J R Roberts, R A McClintock, et al.
Bio/Technology (Nature Publishing Company)
|
June 1, 1993
Optimization of a recombinant von Willebrand factor fragment as an antagonist of the platelet glycoprotein Ib receptor
C P Prior, V Chu, B Cambou, et al.
Blood
|
July 1, 1987
Proteolytic degradation of von Willebrand factor after DDAVP administration in normal individuals
J Batlle, M F Lopez-Fernandez, A Lopez-Borrasca, et al.
Blood
|
December 1, 1986
The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitors
J Batlle, M F Lopez Fernandez, M Campos, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
Journal of Cell Science
|
June 1, 1994
Vimentin's tail interacts with actin-containing structures in vivo
R B Cary, M W Klymkowsky, R M Evans, et al.
The Journal of Biological Chemistry
|
November 15, 1986
Isolation and characterization of a collagen binding domain in human von Willebrand factor
F I Pareti, Y Fujimura, J A Dent, et al.
American Journal of Hematology
|
December 1, 1989
Type II H von Willebrand disease: new structural abnormality of plasma and platelet von Willebrand factor in a patient with prolonged bleeding time and borderline levels of ristocetin cofactor activity
A B Federici, P M Mannucci, R Lombardi, et al.
The Journal of Biological Chemistry
|
April 25, 2000
Modeling and functional analysis of the interaction between von Willebrand factor A1 domain and glycoprotein Ibalpha
S Vasudevan, J R Roberts, R A McClintock, et al.
Bio/Technology (Nature Publishing Company)
|
June 1, 1993
Optimization of a recombinant von Willebrand factor fragment as an antagonist of the platelet glycoprotein Ib receptor
C P Prior, V Chu, B Cambou, et al.
Blood
|
July 1, 1987
Proteolytic degradation of von Willebrand factor after DDAVP administration in normal individuals
J Batlle, M F Lopez-Fernandez, A Lopez-Borrasca, et al.
Blood
|
December 1, 1986
The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitors
J Batlle, M F Lopez Fernandez, M Campos, et al.
Page
of 5